Matrix metalloproteinase-1 induces cleavage of exogenous alphaB-crystallin transduced by a cell-penetrating peptide

J Cell Biochem. 2011 Sep;112(9):2454-62. doi: 10.1002/jcb.23167.

Abstract

Cell-penetrating peptides (CPPs), including TAT-CPP, have been used to deliver exogenous proteins into living cells. Although a number of proteins fused to TAT-CPP can be delivered into various cells, little is known about the proteolytic cleavage of TAT-fusion proteins in cells. In this study, we demonstrate that a small heat shock protein (sHSP), alphaB-crystallin (αB-crystallin), delivered by TAT-CPP is susceptible to proteolytic cleavage by matrix metalloproteinase-1 (MMP-1) in cardiac myoblast H9c2 cells. Recombinant TAT-αB-crystallin was efficiently transduced into H9c2 cells. For a few hours following protein transduction, generation of a 14-kDa fragment, a cleavage band of TAT-αB-crystallin, increased in a time-dependent manner. This fragment was observed only in detergent-insoluble fractions. Interestingly, treatment with MMP inhibitors blocked the cleavage of TAT-αB-crystallin. In test tubes, recombinant MMP-1 processed TAT-αB-crystallin to generate the major cleavage fragment 14-kDa, as observed in the cells treated with TAT-αB-crystallin. The N-terminal sequences of the 14-kDa fragment were identified as Leu-Arg-Ala-Pro-Ser-Trp-Phe, indicating that this fragment is generated by cleavage at Phe54-Leu55 of αB-crystallin. The MMP-1-selective inhibitor abolished the production of 14-kDa fragments in cells. In addition, the cleaved fragment of TAT-αB-crystallin was significantly reduced in cells transfected with MMP-1 siRNA. Moreover, the enzymatic activity of MMP-1 was markedly increased in TAT-αB-crystallin-treated cells. TAT-αB-crystallin has a cytoprotective effect on H9c2 cells under hypoxic insult, moreover, MMP-1-selective inhibitor treatment led to even increased cell viability. These results suggest that MMP-1 is responsible for proteolytic cleavage of TAT-αB-crystallin during its intracellular transduction in H9c2 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Hypoxia
  • Cell Line
  • Cell Survival / drug effects
  • Cell-Penetrating Peptides / isolation & purification
  • Cell-Penetrating Peptides / pharmacokinetics*
  • Cell-Penetrating Peptides / pharmacology
  • Cytoprotection
  • Drug Delivery Systems
  • Enzyme Assays
  • Matrix Metalloproteinase 1 / genetics
  • Matrix Metalloproteinase 1 / metabolism*
  • Myoblasts / drug effects
  • Myoblasts / enzymology
  • Myoblasts / metabolism
  • Rats
  • Recombinant Fusion Proteins / isolation & purification
  • Recombinant Fusion Proteins / pharmacokinetics*
  • Recombinant Fusion Proteins / pharmacology
  • alpha-Crystallin B Chain / isolation & purification
  • alpha-Crystallin B Chain / pharmacokinetics*
  • alpha-Crystallin B Chain / pharmacology
  • tat Gene Products, Human Immunodeficiency Virus / isolation & purification
  • tat Gene Products, Human Immunodeficiency Virus / pharmacokinetics*
  • tat Gene Products, Human Immunodeficiency Virus / pharmacology

Substances

  • Cell-Penetrating Peptides
  • Recombinant Fusion Proteins
  • alpha-Crystallin B Chain
  • tat Gene Products, Human Immunodeficiency Virus
  • Matrix Metalloproteinase 1